2.0
11. Okt. 2014
Mitarbeiter (anonym)
Ehemaliger Mitarbeiter, mehr als 1 Jahr
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
Friendly colleagues; most people of similar level were nice and helpful. Focus on novel pursuit of interesting science. Unclear what could have been.
Kontras
Pfizer merger was a huge drain; too many good people were displaced. Too much in fighting and not enough focus on science that could deliver - not enough asking the right questions.